Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Can XENICAL be taken with other prescription or over-the-counter weight-loss products?

0
Posted

Can XENICAL be taken with other prescription or over-the-counter weight-loss products?

0

Efficacy and safety studies regarding the combined use of XENICAL and other weight-loss products, whether prescription or OTC, have not been conducted. Back to top Safety Q: What are the most common adverse events seen with XENICAL? A: The most commonly reported events (incidence of >5% and twice that of placebo) were oily spotting, flatus with discharge, fecal urgency, fatty/oily stool, oily evacuation, increased defecation and fecal incontinence. These and other commonly observed events were generally mild and transient, and decreased markedly during the second year of treatment. Withdrawal rates due to these events in clinical studies were low. Patients should be educated to expect GI events when taking XENICAL. Q: What was the dropout rate in clinical studies due to GI events? A: Withdrawal rates due to treatment events were low. In controlled clinical trials, 8.8% of patients treated with XENICAL discontinued treatment due to adverse events, compared with 5.0% of placebo-treated p

0

Efficacy and safety studies regarding the combined use of XENICAL and other weight-loss products, whether prescription or OTC, have not been conducted. Back to top Safety Q: What are the most common adverse events seen with XENICAL? A: The most commonly reported events (incidence of >5% and twice that of placebo) were oily spotting, flatus with discharge, fecal urgency, fatty/oily stool, oily evacuation, increased defecation and fecal incontinence. These and other commonly observed events were generally mild and transient, and decreased markedly during the second year of treatment. Withdrawal rates due to these events in clinical studies were low. Patients should be educated to expect GI events when taking XENICAL. Q: What was the dropout rate in clinical studies due to GI events? A: Withdrawal rates due to treatment events were low. In controlled clinical trials, 8.8% of patients treated with XENICAL discontinued treatment due to adverse events, compared with 5.0% of placebo-treated p

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.